EXPERIMENTAL ANTI-CANCER SYNTHETIC MOLECULE TARGETS TUMOR CELL GROWTH AND ANGIOGENESIS
Experimental Anti-cancer Synthetic Molecule Targets Tumor Cell Growth And Angiogenesis
A past study describes a newborn politician anti-cancer drug, HB-19. In oppositeness to customary anti-cancer drugs, HB-19 has a dual mechanism of state by independently targeting tumor radiophone growth and tumor. The molecular target of HB-19 is nucleolin expressed on the surface of every reactive cells, in portion apace growing tumor cells and endothelial cells that endeavor a key persona in angiogenesis.
Dealing With the Diagnosis Part 2 - Apr 3-8
Tags: drugs for cancer, mentality cancer, boob cancer, cancer drugs, wound cancer